{"title":"Incidence Trends and Disease Burden of Vascular Intestinal Disorders: A Population-Based Study in China and Worldwide from 1990 to 2021.","authors":"Lanhui Zeng, Bowen Li, Junhui Gao, Suwei He, Ling Huang","doi":"10.2147/VHRM.S609512","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Vascular intestinal disorders (VID), characterized by inadequate intestinal perfusion, lead to severe complications like tissue ischemia, infarction, and inflammation. This study evaluates global and Chinese VID trends and burden from 1990 to 2021 using Global Burden of Disease (GBD) 2021 data.</p><p><strong>Methods: </strong>Age-standardized incidence, prevalence, mortality, and disability-adjusted life years (DALYs) were extracted. Joinpoint regression analyzed temporal trends, computing average annual percentage changes (AAPC) and 95% confidence intervals. Subgroup analyses covered age, sex, and socio-demographic index.</p><p><strong>Results: </strong>Globally, the age-standardized incidence rate (ASIR) declined from 18.81 to 15.98 per 100,000 (AAPC: -0.52%); in China, it fell from 5.92 to 5.03 (AAPC: -0.50%). However, China's absolute cases nearly doubled due to demographic shifts. Significant gender and age disparities emerged: younger males showed higher ASIR and ASMR, while women ≥75 years had elevated morbidity and mortality.</p><p><strong>Conclusion: </strong>Despite declining age-standardized rates, the absolute VID burden escalates globally and in China. Disparities disproportionately affect elderly women and younger males. Enhanced diagnostics, equitable access, and targeted prevention are urgent. Stakeholders must prioritize integrative VID prevention strategies within non-communicable disease frameworks to mitigate this growing concern.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"22 ","pages":"609512"},"PeriodicalIF":3.2000,"publicationDate":"2026-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13488672/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Health and Risk Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/VHRM.S609512","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Vascular intestinal disorders (VID), characterized by inadequate intestinal perfusion, lead to severe complications like tissue ischemia, infarction, and inflammation. This study evaluates global and Chinese VID trends and burden from 1990 to 2021 using Global Burden of Disease (GBD) 2021 data.
Methods: Age-standardized incidence, prevalence, mortality, and disability-adjusted life years (DALYs) were extracted. Joinpoint regression analyzed temporal trends, computing average annual percentage changes (AAPC) and 95% confidence intervals. Subgroup analyses covered age, sex, and socio-demographic index.
Results: Globally, the age-standardized incidence rate (ASIR) declined from 18.81 to 15.98 per 100,000 (AAPC: -0.52%); in China, it fell from 5.92 to 5.03 (AAPC: -0.50%). However, China's absolute cases nearly doubled due to demographic shifts. Significant gender and age disparities emerged: younger males showed higher ASIR and ASMR, while women ≥75 years had elevated morbidity and mortality.
Conclusion: Despite declining age-standardized rates, the absolute VID burden escalates globally and in China. Disparities disproportionately affect elderly women and younger males. Enhanced diagnostics, equitable access, and targeted prevention are urgent. Stakeholders must prioritize integrative VID prevention strategies within non-communicable disease frameworks to mitigate this growing concern.
期刊介绍:
An international, peer-reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention, and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes. In addition, the journal will also seek to define drug usage in terms of ultimate uptake and acceptance by the patient and healthcare professional.